Sabra Health Care REIT, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Sabra Health Care REIT, Inc. reported Cash And Cash Equivalents At Carrying Value of $71.54 million for the year ending 2025.

  • Sabra Health Care REIT, Inc. showed an increase of +18.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Sabra Health Care REIT, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2011: $80.21 million | Q2 2011: $3.45 million | Q3 2011: $56.42 million | Q1 2012: $2.68 million | Q2 2012: $3.11 million | Q3 2012: $30.48 million | Q1 2013: $53.57 million | Q2 2013: $92.77 million | Q3 2013: $96.64 million | Q1 2014: $4.29 million | Q2 2014: $15.09 million | Q3 2014: $25.48 million | Q1 2015: $4.17 million | Q2 2015: $6.04 million | Q3 2015: $31.47 million | Q1 2016: $9.13 million | Q2 2016: $103.87 million | Q3 2016: $19.67 million | Q1 2017: $12.81 million | Q2 2017: $13.24 million | Q3 2017: $30.87 million | Q1 2018: $46.35 million | Q2 2018: $38.81 million | Q3 2018: $36.35 million | Q1 2019: $22.87 million | Q2 2019: $47.60 million | Q3 2019: $29.43 million | Q1 2020: $54.05 million | Q2 2020: $28.25 million | Q3 2020: $35.03 million | Q1 2021: $24.88 million | Q2 2021: $69.35 million | Q3 2021: $546.34 million | Q1 2022: $24.84 million | Q2 2022: $67.15 million | Q3 2022: $26.29 million | Q1 2023: $33.53 million | Q2 2023: $27.23 million | Q3 2023: $33.26 million | Q1 2024: $59.93 million | Q2 2024: $36.40 million | Q3 2024: $63.00 million | Q1 2025: $22.65 million | Q2 2025: $95.18 million | Q3 2025: $200.60 million.
  • Over the full 17 years of available data (2010 to 2025), Sabra Health Care REIT, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 6.6%.
  • Historical annual values: Fiscal year 2025: $71.54 million | Fiscal year 2024: $60.47 million | Fiscal year 2023: $41.29 million | Fiscal year 2022: $49.31 million | Fiscal year 2021: $112.00 million | Fiscal year 2020: $59.08 million | Fiscal year 2019: $39.10 million | Fiscal year 2018: $50.23 million | Fiscal year 2017: $518.63 million | Fiscal year 2016: $25.66 million | Fiscal year 2015: $7.43 million | Fiscal year 2014: $61.79 million | Fiscal year 2013: $4.31 million | Fiscal year 2012: $17.10 million | Fiscal year 2011: $42.25 million | Fiscal year 2010: $42.25 million | Fiscal year 2010: $67.13 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: